$INTA Cashflow Statement | Understand Stock

$INTA

$42.95 -$4.20 (8.91%) Close

$INTA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Cash Flows from Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Amortization of deferred financing costs
Amortization of operating lease right-of-use assets
Accounts receivable allowances
Stock-based compensation
Lease modification and impairment
Payment of contingent consideration in excess of acquisition date fair value
Change in fair value of contingent consideration
Deferred income taxes
Foreign currency impact from dissolution of subsidiary
Asset impairments
Other

Changes in operating assets and liabilities:
Accounts receivable
Unbilled receivables, current
Prepaid expenses and other assets
Deferred commissions
Accounts payable and accrued liabilities
Deferred revenue, net
Operating lease liabilities
Other liabilities
Net cash provided by operating activities
Cash Flows from Investing Activities:
Purchases of property and equipment
Capitalized internal-use software costs
Business combinations, net of cash acquired
Purchase of strategic investments
Net cash used in investing activities
Cash Flows from Financing Activities:
Payments on borrowings
Proceeds from public offering, net of underwriting discounts
Proceeds from common stock issuance
Payments for deferred offering costs
Proceeds from stock option exercises
Proceeds from employee stock purchase plan
Payments related to tax withholding for vested equity awards
Payments of deferred financing costs
Payments of contingent consideration and holdback associated with acquisitions
Repurchase of shares and fully vested options
Repurchases of common stock
Net cash (used in) provided by financing activities

Effect of foreign currency exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of period
Cash, cash equivalents and restricted cash - end of period
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents
Restricted cash
Total cash, cash equivalents and restricted cash
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid for income taxes, net of tax refunds
Non-Cash Investing and Financing Activities:
Purchases of property and equipment in accounts payable and accrued liabilities
Capitalized internal-use software costs in accounts payable and accrued liabilities
Deferred offering costs in accounts payable and accrued liabilities
Conversion of convertible preferred stock to common stock upon initial public offering
Vesting of early exercised stock options
Deferred consideration included in accounts payable, accrued liabilities and other liabilities
Contingent consideration and acquisition holdbacks in accounts payable, accrued expenses and other liabilities
Issuance of common stock in connection with a business combination
Acquisition holdbacks in other liabilities
Fair value of contingent consideration in accrued and other liabilities
Stock-based compensation expense capitalized in internal-use software costs, net
Cash paid
Cash acquired
Total consideration
Unpaid accrued tax withholding for vested equity awards
Unpaid excise tax on repurchases of common stock
Accrued transaction cost in advance of closing UBS Credit Agreement

Comments